Company: NEGG
Filing Date: 2025-07-15
Form Type: 424B5
Source: 0001213900-25-063944
Chunk: 11

Company: Newegg Commerce, Inc.
Filing Date: 2025-07-15
Form: 424B5
Chunk 11
---
22 per share, the last reported sale price of our Common Shares on Nasdaq on July 14, 2025, for aggregate gross proceeds of $36,220,000,
and after deducting commissions and estimated offering expenses payable by us, new investors in this offering would incur immediate dilution
of $29.34 per share. For a more detailed discussion of the foregoing, see “Dilution” below. To the extent outstanding options
or warrants are exercised or restricted stock units settle, there may be further dilution to investors purchasing Common Shares in this
offering. In addition, to the extent we need to raise additional capital in the future and we issue additional Common Shares or securities
convertible or exchangeable for our Common Shares, our then existing shareholders may experience dilution and the new securities may have
rights senior to those of our Common Shares offered in this offering.

We will have broad discretion over the use of the net proceeds from this offering and may apply it to uses that do not improve our operating results or the value of your securities.

We will have broad discretion to use the net proceeds to us from this offering, and investors will be relying solely on the judgment of our board of directors and management regarding the application of these proceeds. We expect to use the net proceeds from this offering for general corporate purposes and working capital, and we have not allocated the net proceeds for any specific purposes. See “Use of Proceeds” for additional information. Investors will not have the opportunity, as part of their investment decision, to assess whether the proceeds are being used appropriately. Our use of the proceeds may not improve our operating results or increase the value of the securities being offered hereby.

It is not possible to predict the aggregate proceeds resulting from sales made under the Sales Agreement.

Subject to certain limitations in the Sales Agreement and compliance with applicable law, we have the discretion to deliver an issuance notice to the Agent at any time throughout the term of the Sales Agreement. The number of Common Shares, if any, that are sold through the Agent after delivering an issuance notice will fluctuate based on a number of factors, including the market price of our Common Shares during the sales period, any limits we may set with the Agent in any applicable issuance notice and the demand for our Common Shares. It is not currently possible to predict the aggregate proceeds, if any, to be raised in connection with sales under the Sales Agreement.

The Common Shares offered hereby will be sold in “at the market offerings” and investors who buy shares at different times will